Encompass Health declares dividend on common stock
BIRMINGHAM, Ala., July 20, 2021 / PRNewswire / – Encompass Health Corporation (NYSE: EHC) announced today that its board of directors has declared a quarterly cash dividend on its common shares of $ 0.28 per share, payable on October 15, 2021, to registrants on October 1, 2021.
About Encompass Santé
As a national leader in integrated health services, Encompass Health (NYSE: EHC) provides residential and home patient care through its network of inpatient rehabilitation hospitals, home care agencies and palliative care agencies. With a national presence that includes 140 hospitals, 249 home care centers and 94 hospices in 42 states and Porto Rico, the Company provides high-quality, cost-effective integrated health care. Encompass Health is ranked among Fortune’s Top 100 Companies to Work for. For more information, visit entourehealth.com, or follow us on our press room, Twitter, Instagram and Facebook.
Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 . In addition, Encompass Health, through its senior management, may from time to time make forward-looking public statements regarding the matters described herein. All such estimates, projections and forward-looking information speak only as of the date hereof, and Encompass Health assumes no obligation to publicly update or revise such forward-looking information, whether as a result of new information, future events or otherwise. These forward-looking statements are necessarily estimates based on current information and involve a number of risks and uncertainties. Actual events or results may differ materially from those anticipated in these forward-looking statements due to various factors. While it is not possible to identify all of these factors, factors that could cause actual events or results to differ materially from those estimated by Encompass Health include, but are not limited to, the continued spread of COVID-19, including the speed, depth, geographic scope and duration of the spread, which could reduce our patient volumes and revenues and lead to staff and supply shortages and cost increases associates; actions to be taken by Encompass health in response to the pandemic; the results of the strategic review of the home and palliative care segment; legal, regulatory and administrative developments occurring at federal, state and local levels; Encompasses health infectious disease prevention and control efforts; Encompass Health’s ability to comply with the extensive, complex and constantly changing regulations of the healthcare industry; any adverse outcome of various lawsuits, claims and legal or regulatory proceedings involving Encompass Health, including any matter relating to as yet undiscovered issues, if any, in the acquired companies; interruptions, breaches or other potential incidents affecting the proper functioning, availability or security of Encompass Health information systems, including unauthorized access or theft of patients, business associates or other information sensitive; changes, delays (including in connection with resolving Medicare revisions or payment calls) or suspension of reimbursement for Encompass Health services by government or private payers; and other factors which may be identified from time to time in the SEC records and other public announcements of Encompass Health, including Encompass Health Form 10-K for the year ended December 31, 2020 and Form 10-Q for the completed quarter March 31, 2021.
Hillary Carnel | 205-970-5912
Investor Relations Contact:
Crispy Carlisle | 205-970-5860
SOURCE Encompass Health Corp.